Trial Profile
A Phase II Study of Triapine in Combination With Gemcitabine in Patients With Pancreatic Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Aug 2013
Price :
$35
*
At a glance
- Drugs OCX 191 (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Sponsors Vion Pharmaceuticals
- 17 Aug 2005 New trial record.